Cabotegravir

Cabotegravir is a second-generation integrase strand transfer inhibitor used as long-acting injectable HIV pre-exposure prophylaxis and in combination with rilpivirine for HIV-1 maintenance therapy, enabling monthly or bi-monthly dosing. Simson Pharma's Cabotegravir reference standard and impurities support analytical development for this long-acting antiretroviral.

Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) supply high-quality Cabotegravir Reference Standards, pharmacopoeial reference materials, and its related impurities to pharmaceutical manufacturers, CROs, analytical laboratories, universities, and regulatory organizations worldwide. To service the Europe and America market efficiently, Simson Pharma Limited has set up Simson Pharma Global Ltd. in United Kingdom and Simson Pharma Global LLC in USA respectively.

Pharmaceutical Reference Standards / Impurity Standards

Cabotegravir Sodium
Cabotegravir
Cabotegravir O-beta-D-Glucuronide
Cabotegravir Impurity 1
Methyl Cabotegravir
Cabotegravir Desalkyl Impurity
Cabotegravir 2,6-Difluoro impurity
4-Fluoro Cabotegravir
Cabotegravir Des-fluoro Impurity
Cabotegravir Impurity 2
Cabotegravir Impurity 3
2-Fluoro Cabotegravir
Cabotegravir Impurity 4
Cabotegravir Impurity 10
N-Nitroso Cabotegravir
Cabotegravir Impurity 11
Cabotegravir Impurity 12
Cabotegravir Hydroxy Impurity
Cabotegravir Impurity 5

Metabolites

M2 Metabolite Of Cabotegravir

Isotope Labelled Compounds

Cabotegravir-D5
Cabotegravir-D3
Cabotegravir-D3 Sodium